In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Commentary|Podcasts|November 9, 2023
Public Health Matters - The Prescription Shoppe With Jade Ranger
Dr. Christina Madison, speaks with Dr. Jade Ranger, from the Prescription Shoppe in this episode of Public Health matters.
Advertisement
Dr. Christina Madison, engages in a discussion with Dr. Jade Ranger, from the Prescription Shoppe. They talk about their various experiences and journeys through pharmacy.
Key Takeaways:
- The Prescription Shop is approaching its five-year anniversary, a significant milestone for businesses, and they plan to celebrate with a special event in March 2024.
- Dr. Ranger emphasizes the importance of going beyond traditional pharmacy services, acting as a resource for patients who may need health advice or support. The pharmacy aims to make a difference beyond the counter, focusing on overall community health and well-being.
- Building relationships with patients is a key aspect of community pharmacy. Dr. Ranger shares examples of patients confiding in her about personal matters, highlighting the role of pharmacists as trusted healthcare professionals.
- The Prescription Shop collaborates with the health department on various initiatives, including featuring in commercials, supporting HIV patients, and offering travel vaccines. The partnership with the health department enhances the pharmacy's visibility and services in the community.
Advertisement
Related to this article
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
2
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
5